We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.48%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$111B
AUM Growth
+$4.45B
(+4.2%)
Cap. Flow
-$1.78B
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
29%
Holding
4,480
New
63
Increased
1,265
Reduced
2,421
Closed
236
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$46M |
| 2 |
Palantir
PLTR
|
+$40.3M |
| 3 |
SW
Smurfit Westrock
SW
|
+$39.2M |
| 4 |
Dell
DELL
|
+$29.2M |
| 5 |
Avantor
AVTR
|
+$27.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$97.8M |
| 2 |
Eli Lilly
LLY
|
+$58.2M |
| 3 |
NVIDIA
NVDA
|
+$48.6M |
| 4 |
ExxonMobil
XOM
|
+$31.3M |
| 5 |
Bank of America
BAC
|
+$30.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.19% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 11.38% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Industrials | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Nektar Therapeutics
NKTR
$2.58B
| $238K | ﹤0.01% |
12,209
-132
| -1% | -$2.52K |
|
2952
iShares MSCI Turkey ETF
TUR
$217M
| $237K | ﹤0.01% |
6,520
| – | – |
|
2953
Richardson Electronics
RELL
$304M
| $237K | ﹤0.01% |
19,215
+2,009
| +12% | +$23.6K |
|
2954
RGC Resources
RGCO
$228M
| $237K | ﹤0.01% |
10,500
+1,162
| +12% | +$24.2K |
|
2955
Future Fuel
FF
$223M
| $237K | ﹤0.01% |
41,184
-1,166
| -3% | -$6.47K |
|
2956
Pyxis Oncology
PYXS
$236M
| $236K | ﹤0.01% |
64,428
-859
| -1% | -$3.01K |
|
2957
TScan Therapeutics
TCRX
$52M
| $235K | ﹤0.01% |
47,203
+336
| +0.7% | +$2.03K |
|
2958
Alto Neuroscience
ANRO
$1.11B
| $235K | ﹤0.01% |
20,548
+10,009
| +95% | +$122K |
|
|
NJ
2959
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
| $234K | ﹤0.01% |
22,319
+1,765
| +9% | +$18.5K |
|
2960
Ascendis Pharma A/S
ASND
$16.8B
| $234K | ﹤0.01% |
1,568
+35
| +2% | +$4.73K |
|
2961
WPP
WPP
$5.94B
| $234K | ﹤0.01% |
4,575
+235
| +5% | +$11.2K |
|
2962
Choiceone Financial
COFS
$510M
| $233K | ﹤0.01% |
7,554
-40
| -0.5% | -$1.15K |
|
2963
America Movil
AMX
$71.2B
| $231K | ﹤0.01% |
14,121
| – | – |
|
2964
First Western Financial
MYFW
$306M
| $231K | ﹤0.01% |
11,533
-416
| -3% | -$7.58K |
|
2965
Compass Therapeutics
CMPX
$387M
| $231K | ﹤0.01% |
125,294
-6,495
| -5% | -$8.1K |
|
2966
ProFrac Holding
ACDC
$787M
| $230K | ﹤0.01% |
33,928
-1,761
| -5% | -$12.3K |
|
|
FRGE
2967
DELISTED
Forge Global Holdings
FRGE
| $230K | ﹤0.01% |
11,720
+1,343
| +13% | +$28K |
|
|
YALA
2968
Yalla Group
YALA
$832M
| $230K | ﹤0.01% |
50,565
+710
| +1% | +$2.97K |
|
2969
Lexicon Pharmaceuticals
LXRX
$1.1B
| $229K | ﹤0.01% |
145,939
-6,846
| -4% | -$12.2K |
|
|
ARTV
2970
Artiva Biotherapeutics
ARTV
$551M
| $229K | ﹤0.01% |
+14,829
| New | +$172K |
|
2971
NET Power
NPWR
$134M
| $228K | ﹤0.01% |
32,570
+3,834
| +13% | +$32.2K |
|
2972
NI Holdings
NODK
$320M
| $228K | ﹤0.01% |
14,532
+2,335
| +19% | +$35.5K |
|
|
ADVM
2973
DELISTED
Adverum Biotechnologies
ADVM
| $227K | ﹤0.01% |
32,329
+1,508
| +5% | +$10.9K |
|
2974
Blink Charging
BLNK
$87.9M
| $226K | ﹤0.01% |
131,377
-1,678
| -1% | -$4K |
|
|
AOMR
2975
Angel Oak Mortgage REIT
AOMR
$209M
| $226K | ﹤0.01% |
21,655
+3,257
| +18% | +$37.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2024 Portfolio in Review
As of Q3 2024, RhumbLine Advisers held 4,480 positions worth $111B, up 4.2% from $106B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
RhumbLine Advisers's Q3 2024 filing shows 63 new, 1,265 increased, 2,421 reduced and 236 closed positions. Its largest new stake was Smurfit Westrock: 860,959 shares worth $42.5M. The largest sale was Microsoft, an estimated $97.8M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2024 buy was Smurfit Westrock: 860,959 shares worth $42.5M.
- RhumbLine Advisers added most to Apple in Q3 2024, an estimated $46M increase.
- RhumbLine Advisers's biggest Q3 2024 reduction was Microsoft, cutting an estimated $97.8M.
- RhumbLine Advisers fully exited Expand Energy Corp in Q3 2024, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 29% of its $111B portfolio in Q3 2024.
- RhumbLine Advisers opened 63 new positions and closed 236 in Q3 2024.
- RhumbLine Advisers's portfolio value rose 4.2% quarter-over-quarter to $111B.
Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.